Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021



MedExecWomen Invites Women in Life Sciences to Join the 2021 Annual Conference in Boston in October

MedExecWomen, a non-profit organization focused on empowering female executives to accelerate the positive impact of medical devices, diagnostics, drug delivery, and digital healthcare around the world, is hosting the second MedExecWomen Annual Conference for women in the life sciences industry later this month in Boston. This year’s conference will be in person on Oct. 26, 2021, at the Sheraton Boston in Back Bay and registration is now open.

The upcoming conference, Medical Innovation in a Post-Covid World, will be a one-day meeting featuring expert panelists — some of the top physicians and leaders in the life science and medical device industries — discussing the state of the market and several of the biggest ongoing industry challenges and how to overcome them, including:

  • Analyst opinions on the state of the medtech sector
  • COVID changes for how medtech companies lead global organizations and expand commercial operations
  • Where inpatient procedures are going
  • Inequities in healthcare spanning clinical trial participation, patient education and hesitancy, healthcare delivery, and access
  • How to become a board member
  • Ongoing innovation in digital health technologies
  • Healthcare financial pressure due to COVID and ongoing hospital operational practices

“You’ll be joining as many as 150 executive life science women to dig deeper into these important topics and have conversations with experts across the industry,” said Co-founder of MedExecWomen and President and Founder of Medi-Vantage, Maria Shepherd. “There are so many challenges now and into 2022, and we expect even more change in this new normal. In Boston, our medtech expert panelists are going to provide some real insight into what they foresee.”

Full COVID precautions, including masking, ensuring that all registrants are fully vaccinated, and social distancing are being taken to ensure your safety at this important meeting.

Interested in attending? Registration is open at:

A full agenda is available at:


Other Articles

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Eliaz Therapeutics is Raising Capital

The XGAL3® therapeutic apheresis device is the early-mover for the treatment of AKI. ETI has demonstrated significant survival benefits in preclinical models and their prototype device has successfully removed GAL-3 from human blood plasma.

Veranex Announces Acquisition of IMMR

IMMR, a leading preclinical science organization that provides preclinical research, pathology evaluation and surgical training services to medical technology innovators.

By using this website you agree to accept Medical Device News Magazine Privacy Policy